While infliximab is commonly used for treating inflammatory conditions such as inflammatory bowel disease, paradoxical sarcoidosis secondary to tumor necrosis factor alpha (TNF-α) inhibitors is a rare complication. This evidence concerns the gene TNF and inflammatory bowel disease.